Pharmaceutical

Evotec partners with Crohn’s & Colitis Foundation for IBD therapies

Evotec has announced a collaboration with the Crohn's & Colitis Foundation to advance drug discovery and develop new therapies for IBD.

Jan 11, 2024 - 18:00
Evotec partners with Crohn’s & Colitis Foundation for IBD therapies
Evotec has announced a collaboration with the Crohn's & Colitis Foundation to advance drug discovery and develop new therapies for IBD.
Read the original article

Tags:

Previous Article

BridgeBio gears up for FDA review of acoramidis following Phase III results

Next Article

3M Health receives grant to develop wound treatment solutions in US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase

J&J expands atopic dermatitis scope with $1.25bn Numab ...

May 29, 2024

Access to new tools to combat RSV in babies likely to prove challenging

Access to new tools to combat RSV in babies likely to p...

Oct 6, 2023

LUNA-18 by Chugai Pharmaceutical for Solid Tumor: Likel...

May 17, 2024